Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | Case report

Multiple drugs

Pancytopenia, panniculitis at the injection site and ​lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lotscher F, et al. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease. Frontiers in Immunology 12: 800149, 20 Jan 2022. Available from: URL: http://doi.org/10.3389/fimmu.2021.800149 Lotscher F, et al. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease. Frontiers in Immunology 12: 800149, 20 Jan 2022. Available from: URL: http://​doi.​org/​10.​3389/​fimmu.​2021.​800149
Metadaten
Titel
Multiple drugs
Pancytopenia, panniculitis at the injection site and ​lack of efficacy: case report
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12249-z

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Dinoprostone

Case report

Metamfetamine

Case report

Atezolizumab

Case report

Multiple drugs